Palma de Mallorca
May 12-14, 2027
Check out the preliminary scientific programme and explore the outstanding lineup of confirmed speakers who will shape 2027’s edition discussions. Dive into the sessions, discover the experts behind them, and start planning your experience—this edition promises exceptional insights and meaningful scientific exchange

Cancer Biology

Fundamental insights into cancer cell behaviour, tumour biology and molecular mechanisms.

Cancer Evolution

Understanding how tumours evolve, adapt and develop resistance over time.

Early Cancer Detection

Novel liquid biopsy strategies for detecting cancer at its earliest, most treatable stages.

Minimal Residual Disease (MRD)

Latest methods for MRD detection and characterization to guide post-treatment monitoring.

Disease Monitorization and RECIST-ctDNA

Integrating ctDNA dynamics with radiological response criteria for precision monitoring.

Liquid Biopsy in Clinical Trials

Expanding the role of liquid biopsy as a biomarker endpoint in oncology trials.

Multimodal Data Integration

Combining genomic, proteomic, and clinical data for comprehensive cancer profiling.

Emerging Technologies and Biomarkers

Cutting-edge platforms and novel biomarkers shaping the future of liquid biopsy.

Cancer Immunotherapy

Liquid biopsy applications in monitoring and predicting immunotherapy response.